Can platelet purinergic receptors be targeted to safely treat non-thrombotic diseases?
-
Chair(s):
Clive Page,
Professor of Pharmacology,King's College London, London, United KingdomDingxin Pan,
Postdoctoral Fellow,King's College London, London, United Kingdom -
Session description:
Platelet activation during inflammation and evidence for biased signalling via P2Y1
Dr Simon Pitchford
Senior Lecturer in Pharmacology, King's College London, London, United KingdomThe role of the platelet P2Y12 receptor in inflammation
Professor Robert Storey
Professor of Cardiology, University of Sheffield, Sheffield, United KingdomOral communication speaker - to be confirmed in 2022.
The Role of P2Y1 and P2Y14 receptors in non-thrombotic platelet functions
Kate Arkless
King's College London United Kingdom, London, United KingdomNovel pharmacophores and ligand docking analyses to probe P2Y1 and P2Y12 receptor activation.
Professor Kenneth Jacobson
National Institutes of Health, Bethesda, The United States of America -
Sponsored by:
Speakers
-
Dr Simon PitchfordSenior Lecturer in Pharmacology, King's College London, London, United Kingdom
-
Kate ArklessKing's College London United Kingdom, London, United Kingdom
-
Professor Kenneth JacobsonNational Institutes of Health, Bethesda, The United States of America
-
Professor Robert StoreyProfessor of Cardiology, University of Sheffield, Sheffield, United Kingdom
Leave A Comment